GlobeNewswire

Toronto Wolfpack Partners With International Cannabis and Organic Flower to Release CBD-Infused Topical Cream ‘Rugby Strength’

Share

TORONTO, May 12, 2019 (GLOBE NEWSWIRE) -- Toronto Wolfpack RLFC (“Toronto Wolfpack”) is set to become the first professional sporting team to enter the thriving CBD-infused products marketplace. Toronto Wolfpack and its 100% owned subsidiary HowlBrands Inc. have entered into a definitive agreement with ICC International Cannabis Corp. (CSE: WRLD.U)(FWB:8K51)(OTC: WLDCF) and Organic Flower Investments Group Inc. (CSE: SOW)(FWB:2K6)(OTC: QILFF) to launch a suite of athlete-focused cannabidiol products to market.

Toronto Wolfpack and HowlBrands plan to release their inaugural CBD-infused topical cream, ‘Rugby Strength’, in the coming months. Rugby Strength is custom-formulated to combat acute aches and pains and absorbs quickly to deliver strong and deep-seated relief. It is made with full-spectrum CBD extract from 100% organically grown hemp and blend of natural ingredients, containing zero THC and therefore has no psychoactive effects.

This new venture sees the Wolfpack stepping into the CBD market that has been estimated to reach US$22 billion by 2022, while looking to modernise the way not just athletes but everyone deals with pain.

HowlBrands
HowlBrands is a branding and product development company at the nexus of sports and wellness with a special focus on CBD. David Argyle, Chairman of the Toronto Wolfpack spoke regarding the unprecedented venture:

“HowlBrands aims to interact with consumers within, across and beyond rugby and sports. In the same way that one does not have to be an athlete or play sports to wear Nike shoes, one does not have to be an athlete or play sports to use Rugby Strength or other HowlBrands products. Anyone who experiences pain, soreness or physical discomfort can use Rugby Strength.”

Eva Allouche, Head of Global Brands for HowlBrands, discussed the goal of the partner-ship:

“Our goal is to bridge the gap between professional sports and CBD to offer athletes, active people and anyone who experiences physical discomfort, a range of unique wellness products that deliver the indisputable therapeutic benefits of hemp-based CBD. HowlBrands is about more than offering a pain solution for athletes and active people, it is about deepening the meaning of wellness through brands that open up the discourse around holistic approaches to taking proper care of ourselves. HowlBrands is about enriching the lives of people.”

Go-To-Market Strategy
HowlBrands launch strategy will be executed online in the US and UK and will leverage an expansive distribution network of 80,000 retail outlets and pharmacies as well as GMP certified facilities.
International Cannabis and Organic Flower are critical to a worldwide distribution plan that will see several CBD-infused product lines becoming available through HowlBrands. This includes topical creams, therapeutic relief balms, sport pain tinctures, soaks and roll-ons, all uniquely engineered to be fast-absorbing and deeply penetrating.
In line with the core values of the Toronto Wolfpack, a portion of the proceeds from Rugby Strength will be reinvested into the development of rugby around the world.

Manufacturing
All HowlBrands products, including Rugby Strength, are developed and formulated by a team of medical professionals and natural health experts and are manufactured with THC-free, CBD extract from organically grown hemp. Our manufacturing partners comply with the industry’s highest standards and provide full, batch-specific documentation. All results are corroborated by rigorous third-party testing and all our products come with THC-free, non-GMO, gluten free, vegan and organic accreditation.

About the Wolfpack
Toronto Wolfpack are a professional Rugby team dedicated to progressing through the Rugby League Football's ranks, from League 1 to the Super League. We are the first North American team to play in the RFL and the world’s first transatlantic professional sports team. The Wolfpack organization is driven by the belief that the world is a better place with more rugby balls in kids’ hands. We also aspire to create a global centre for rugby excellence in Toronto, to showcase the best of Ontario by supporting family run local businesses and to actively promote transatlantic trade between North American and UK partners.

Toronto Wolfpack’s impressive and ever-growing media profile includes a broadcast reach to over 140 million homes, in-stadium attendances of up to 9,500 fans at home games during the RFL Championship, highly acclaimed game day experience and a social media presence of over 100,000 verified followers has seen the Club grown from strength to strength each year.

Currently sitting at the top of the RFL Championship table with a record of 12-1 in a league boasting teams from the UK, France and Canada, the Wolfpack have their sights firmly set on achieving the goal of Super League promotion for the 2020 season.

Learn more about Howl’s product range at: www.howlbrands.com

Learn more about the Toronto Wolfpack at: www.torontowolfpack.com
Twitter: @TOwolfpack
Instagram: torontowolfpackofficial
Facebook: TorontoWolfpack

For media inquiries, please contact:
Erik Grosman +1 (647) 204-9655 / erik.grosman@torontowolfpack.com
Martin Vickers +44 7808 556315 / martin@torontowolfpack.com

Notice Regarding Forward Looking Information:
This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. For-ward-looking information includes, but is not limited to statements regarding: the Toronto Wolfpack’s position and role in the CBD market; the Toronto Wolfpack’s goal of Super League promotion; the Toronto Wolfpack’s go-to-market strategy; the effectiveness of the Toronto Wolfpack and HowlBrands products; political changes in Canada and internationally, future legislative and regulatory developments involving cannabis in Canada and internationally, Toronto Wolfpack’s ability to secure distribution channels in international jurisdictions, competition and other risks affecting Toronto Wolfpack in particular and the cannabis industry generally. 
The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, Toronto Wolfpack and HowlBrands do not undertake any obligation to publicly update or revise any forward- looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Photos accompanying this announcement are available at

http://www.globenewswire.com/NewsRoom/AttachmentNg/37cc0fbe-ca83-49eb-a3a4-5b0220e1a4a3

http://www.globenewswire.com/NewsRoom/AttachmentNg/a548879a-55de-4937-b9c8-c3af581bffc9

http://www.globenewswire.com/NewsRoom/AttachmentNg/40bec302-ac69-48ad-99f4-80917c0638da

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

SDRL – Seadrill Limited Announces Contract Award for the West Gemini17.7.2019 22:35:00 CESTPress release

Hamilton, Bermuda, July 17, 2019 - Seadrill Limited ("Seadrill" or "the Company") has secured a nine well contract with three options, each for two wells, for the West Gemini in West Africa. Total contract value for the firm portion of the contract is expected to be approximately $84 million with commencement expected in early Q4 2019 and running through Q4 2020. FORWARD LOOKING STATEMENTS This news release includes forward looking statements. Such statements are generally not historical in nature, and specifically include statements about the Company's plans, strategies, business prospects, changes and trends in its business, the markets in which it operates and its restructuring efforts. These statements are made based upon management's current plans, expectations, assumptions and beliefs concerning future events impacting the Company and therefore involve a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed or imp

GrandVision confirms HAL and EssilorLuxotica are engaged in discussions on a possible sale of controlling interest of HAL in GrandVision17.7.2019 18:45:00 CESTPress release

Schiphol, The Netherlands - 17 July 2019. GrandVision NV (Euronext: GVNV) confirms that it has been approached by EssilorLuxottica SA (Euronext: EL) and HAL Holding NV (Euronext: HAL) in connection with a possible sale of HAL’s 76.72% ownership interest in GrandVision to EssilorLuxottica at an envisaged purchase price per share of approximately EUR28.00. At this stage it is uncertain whether an agreement between EssilorLuxottica and HAL will be reached. While a transaction would be between HAL and EssilorLuxottica, GrandVision’s support has been requested. Completion of a sale of HAL’s ownership interest in GrandVision would be subject to customary conditions including approval from relevant regulatory authorities in various jurisdictions, which may take between 12 and 24 months. Following completion of the transaction between HAL and EssilorLuxottica, EssilorLuxottica will make a (mandatory) public offer for all shares in GrandVision. Further announcements will be made if and when req

Solutions 30 : 79.8% revenue growth in the first half of 201917.7.2019 18:00:00 CESTPress release

79.8% revenue growth in the first half of 2019 France: revenue up 74.4% Other countries: revenue up 90.3% Reliable, cash-generating model Solutions 30 SE, the European leader in solutions for new technologies, today disclosed its revenue for the first half of 2019 . In millions of euros (Unaudited figures) HY Q2 2019 2018 % change 2019 2018 % change Total 317.8 176.7 +79.8% 157.4 91.5 +72.1% From France 202.8 116.3 +74.4% 101.5 59.5 +70.6% From other countries 115.0 60.4 +90.3% 55.9 32.0 +74.7% Sustained growth trend continues Solutions 30 maintains its high growth trajectory, disclosing revenues of €317.8 million for the first half of 2019, a 79.8% increase (36.9% of which was organic growth1). For the 2nd quarter alone, revenue increased by 72.1%, reaching €157.4 million. Organic growth represented 32.3%. The group continues to demonstrate the relevance of its positioning and strategy in markets driven by the economy’s digital transformation and major technology groups’ outsourcing o

ObsEva Hosts KOL Meeting on IVF Trends, Unmet Need and Market Potential of Nolasiban17.7.2019 18:00:00 CESTPress release

Company remains on track to submit Nolasiban MAA in the fourth quarter of 2019 GENEVA, Switzerland and BOSTON, MA - July 17, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy, today hosted a key opinion leader (KOL) meeting in New York City on in-vitro fertilization (IVF). At the event, three KOLs in women’s reproductive health along with company executives discussed trends in IVF, including current practice trends toward Day 5 embryo transfer, and the merits of single-embryo transfer (SET) vs. double embryo transfer (DET). Further, event participants discussed the potential clinical importance of nolasiban, ObsEva’s oral oxytocin receptor antagonist, to significantly improve the live birth rate (LBR) resulting from ET, and address the high physical, emotional and financial pain associated with fa

Bizagi goes from Stealth to Hyper Growth Delivering Digital Transformation for World Leading Brands17.7.2019 18:00:00 CESTPress release

From Adidas and Audi to Ikea and the U.S. government, Bizagi’s unique Intelligent Process Automation helping organizations harness the power of RPA and AI to speed transformation SANTA CLARA, Calif., July 17, 2019 (GLOBE NEWSWIRE) -- Bizagi, the world’s leading Intelligent Process Automation platform provider, today announced significant growth in the U.S. and abroad driven by its success enabling digital transformation for world leading brands such as DHL, Gap, Citizens Bank, AON and numerous U.S. government agencies including the Departments of Agriculture, Defense, Energy, HHS, Homeland Security and many others. Bizagi’s growth is based on enterprise adoption of its unique Intelligent Process Automation, enabling companies to better leverage digital and robotic processes, along with artificial intelligence, to improve customer interaction, speed operations and build revenue. This news follows the company’s recognition last month as a leader in The Forrester Wave™: Software for Digit

EnBW International Finance B.V.: Half-yearly report17.7.2019 17:00:00 CESTPress release

EnBW International Finance B.V.: Half-yearly report 2019 In accordance with the Transparency Directive (Directive 2004/109/EC), as amended by the Transparency Directive Amending Directive (Directive 2013/50/EU), and following the choice of EnBW International Finance B.V. for The Netherlands as Home Member State, EnBW International Finance B.V. hereby informs that the half-year financial reports for the period 1 January 2019 till 30 June 2019 have been filed on 17 July 2019 with the Autoriteit Financiële Markten (AFM) in The Netherlands and are available on the internet site: https://www.enbw.com/unternehmen/investoren/news-und-publikationen/publikationen/